CorMedix Inc. /
Melinta Therapeutics, LLC
CorMedix Completes Merger With Melinta Therapeutics




Source for the buyer and target: CorMedix Inc.
For the buyer and target.
“On August 29, 2025 (the “Closing Date”), CorMedix Inc., a Delaware corporation (the “Company,” “CorMedix,” “we,” “our” and “us”) completed its previously announced merger with Melinta Therapeutics, LLC, a Delaware limited liability company (“Melinta”).”
Published 2 Sep 2025
Open the sourceWhat happened
CorMedix Inc. completed its merger with Melinta Therapeutics, LLC on Aug. 29, 2025. Melinta survived the merger as a wholly owned subsidiary of CorMedix Inc. [01]
CorMedix paid Melinta equityholders $260 million in cash and $40 million worth of common shares. Contingent payments may also be made under the merger terms. [01]
The source
Everything on this page comes from the source below, quoted word for word.
CorMedix Completes Merger With Melinta Therapeutics
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Closed
“CorMedix Completes Merger With Melinta Therapeutics CorMedix Inc. completed its merger with Melinta Therapeutics, LLC on Aug. 29, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly